89 related articles for article (PubMed ID: 23398946)
1. Decreased mortality associated with statin treatment in patients with acute myocardial infarction and lymphotoxin-alpha C804A polymorphism.
Suna S; Sakata Y; Nakatani D; Okuda K; Shimizu M; Usami M; Matsumoto S; Hara M; Ozaki K; Mizuno H; Minamino T; Takashima S; Nishino M; Matsumura Y; Takeda H; Tanaka T; Sato H; Hori M; Komuro I
Atherosclerosis; 2013 Apr; 227(2):373-9. PubMed ID: 23398946
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study.
Chiodini BD; Franzosi MG; Barlera S; Signorini S; Lewis CM; D'Orazio A; Mocarelli P; Nicolis E; Marchioli R; Tognoni G; ;
Eur Heart J; 2007 Aug; 28(16):1977-83. PubMed ID: 17567623
[TBL] [Abstract][Full Text] [Related]
3. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
Foody JM; Rathore SS; Galusha D; Masoudi FA; Havranek EP; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2006 Mar; 54(3):421-30. PubMed ID: 16551308
[TBL] [Abstract][Full Text] [Related]
4. Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.
Trompet S; de Craen AJ; Slagboom P; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Ford I; Gaw A; Macfarlane PW; Packard CJ; Stott DJ; Westendorp RG; Jukema JW;
Exp Gerontol; 2008 Aug; 43(8):801-5. PubMed ID: 18504081
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
6. Lymphotoxin-alpha polymorphisms and the risk of endometrial cancer in Japanese subjects.
Niwa Y; Ito H; Matsuo K; Hirose K; Ito N; Mizuno M; Hamajima N; Tajima K; Nakanishi T
Gynecol Oncol; 2007 Mar; 104(3):586-90. PubMed ID: 17045328
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study.
Daskalopoulou SS; Delaney JA; Filion KB; Brophy JM; Mayo NE; Suissa S
Eur Heart J; 2008 Sep; 29(17):2083-91. PubMed ID: 18664465
[TBL] [Abstract][Full Text] [Related]
8. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
[TBL] [Abstract][Full Text] [Related]
9. Lymphotoxin-alpha3 mediates monocyte-endothelial interaction by TNFR I/NF-kappaB signaling.
Suna S; Sakata Y; Shimizu M; Nakatani D; Usami M; Matsumoto S; Mizuno H; Ozaki K; Takashima S; Takeda H; Tanaka T; Hori M; Sato H
Biochem Biophys Res Commun; 2009 Feb; 379(2):374-8. PubMed ID: 19103156
[TBL] [Abstract][Full Text] [Related]
10. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
[TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
12. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
Nagashima M; Koyanagi R; Kasanuki H; Hagiwara N; Yamaguchi J; Atsuchi N; Honda T; Haze K; Sumiyoshi T; Urashima M; Ogawa H;
Am J Cardiol; 2007 Jun; 99(11):1523-8. PubMed ID: 17531574
[TBL] [Abstract][Full Text] [Related]
13. Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction.
Kim MC; Cho JY; Jeong HC; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Seung KB; Chang K; Ahn Y
Am J Cardiol; 2015 Jan; 115(1):1-7. PubMed ID: 25456863
[TBL] [Abstract][Full Text] [Related]
14. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
[TBL] [Abstract][Full Text] [Related]
15. Relation of statin therapy to risk of heart failure after acute myocardial infarction.
Aronson D; Mutlak D; Lessick J; Kapeliovich M; Dabbah S; Markiewicz W; Beyar R; Hammerman H; Reisner S; Agmon Y
Am J Cardiol; 2008 Dec; 102(12):1706-10. PubMed ID: 19064028
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
Fonarow GC; Wright RS; Spencer FA; Fredrick PD; Dong W; Every N; French WJ;
Am J Cardiol; 2005 Sep; 96(5):611-6. PubMed ID: 16125480
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
[TBL] [Abstract][Full Text] [Related]
18. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
19. Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age.
Zhou Z; Rahme E; Pilote L
Am J Cardiol; 2006 Jan; 97(2):155-9. PubMed ID: 16442354
[TBL] [Abstract][Full Text] [Related]
20. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
